Previous close | 14.21 |
Open | 14.14 |
Bid | 14.99 x 1000 |
Ask | 15.00 x 3200 |
Day's range | 13.97 - 15.05 |
52-week range | 4.72 - 18.55 |
Volume | |
Avg. volume | 3,387,406 |
Market cap | 3.416B |
Beta (5Y monthly) | 1.82 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEW YORK, February 07, 2024--Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the fourth quarter and full year ended December 31, 2023.
NEW YORK, January 26, 2024--Oscar Health, Inc. ("Oscar") (NYSE: OSCR), a leading healthcare technology company, announced that on January 22, 2024 the Compensation Committee of Oscar’s Board of Directors approved the grant of employment inducement restricted stock unit awards covering an aggregate of 104,586 Class A shares of Oscar’s common stock to 11 new non-executive employees of Oscar and its affiliates, to induce them to join Oscar and its affiliates. The awards generally vest quarterly ove
NEW YORK, January 18, 2024--Oscar Health, Inc. ("Oscar") (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2023 financial results after the market closes on Wednesday, February 7, 2024.